IMPLANET Signs an Exclusive Distribution Contract for SMTP Technology Co.’s Ultrasonic Surgical Scalpel in France

IMPLANET | November 23, 2022 | Read time : 03:00 min


IMPLANET a medical technology company specializing in vertebral implants, announces the signing of an agreement with SMTP Technology Co., a high-tech medical device company specialized in the manufacturing and marketing of ultrasonic medical equipment, for the exclusive distribution of its latest generation ultrasonic surgical scalpel in France.

Adam Li, GMA & International Business Manager at SMTP Technology Co., stated: “We are delighted with the signing of this contract tying us to IMPLANET, which will henceforth ensure the distribution of our latest generation ultrasonic surgical scalpel. This innovative solution will increase surgical efficiency while ensuring greater patient safety. Thanks to this collaboration with IMPLANET, a company recognized for its expertise in the field of spine surgery and its foothold in French medical centers, we are strengthening the credibility of our solutions for their international deployment”.

This latest contract, which comes close on the heels of the commercial and technological partnership signed with Sanyou Medical, further emphasizes the pertinence of our repositioning on the spine market. The surgical scalpel developed by SMTP, through its innovation and ease of use, should meet the needs of surgeons and patients alike. IMPLANET is proud to be able to work with one of the only players in the world capable of developing this type of product based on ultrasound”.

Ludovic Lastennet, IMPLANET’s Chief Executive Officer

The ultrasonic surgical scalpel developed by SMTP Technology Co. can support both open surgery, minimally invasive surgery and endoscopic intervertebral spine surgery. This product, which has been granted marketing clearance in China, the European Union and the United States, stands out through its innovative design, guaranteeing enhanced surgical safety. Thanks to the smaller amplitude of its cutting tip, the scalpel cuts bone tissue by the acceleration of hundreds of thousands of mechanical vibrations per second while sparing soft tissue.

The agreement signed today between IMPLANET and SMTP Technology Co. follows the signing of the distribution contract and technological partnership with Sanyou Medical, of which SMTP Technology Co. is a subsidiary. This new agreement gives IMPLANET exclusive rights to distribute the scalpel on the French market.

SMTP Technology Co., founded in 2010, is a high-tech medical device company focusing on the innovative research and development, manufacturing and marketing of ultrasonic surgical equipment. The ultrasonic osteotomy surgical system manufactured by SMTP Technology, which supports both open surgery and minimally invasive surgery under the channel and intervertebral endoscope, has been granted marketing approval in China, the European Union and the United States. Based in the Zhangjiagang free trade zone in Jiangsu province, SMTP is a subsidiary of the Sanyou group with 100 employees and revenue of 14 million euro.

Founded in 2007, IMPLANET is a medical technology company that manufactures high-quality implants for orthopedic surgery. Its activity revolves around a comprehensive innovative solution for improving the treatment of spinal pathologies complemented by the product range offered by Orthopaedic & Spine Development (OSD), acquired in May 2022. Implanet’s tried-and-tested orthopedic platform is based on the traceability of its products. Protected by four families of international patents, JAZZ® has obtained 510(k) regulatory clearance from the Food and Drug Administration in the United States, the CE mark in Europe and ANVISA approval in Brazil. IMPLANET employs 39 staff and recorded a consolidated revenue of €6.1 million in 2021. Based near Bordeaux in France, IMPLANET opened a US subsidiary in Boston in 2013. IMPLANET is listed on the Euronext Growth market in Paris. 


G-20 First Health Working delegates visited KIMS Health to learn about its innovative healthcare practices and technology, including its commitment to Medical Value Travel and Wellness.


G-20 First Health Working delegates visited KIMS Health to learn about its innovative healthcare practices and technology, including its commitment to Medical Value Travel and Wellness.

Related News


TytoCare and Baptist Health Collaborate for Virtual Medical Care

Media7 | December 13, 2022

Contents 1. Virtual Medical Service Providers 2. Need For Virtual Care 3. Collaborating For A Better Future Taking medical care to the next level, two prominent U.S. companies recently collaborated to provide virtual care to current and prospective patients worldwide. Baptist Health System, based in Louisville, will reportedly use TytoCare's Home Smart Clinic solution to give its patients a virtual in-depth exam. 1. Virtual Medical Service Providers TytoCare, known for its primary virtual care services, works with prominent healthcare providers to give the best care possible. Dedi Gilad and Ofer Tzadik started TytoCare in 2012. It has been approved by both the FDA and the C.E. This New York-based company works with more than 180 primary health systems, health plans, and strategic partners in the U.S., Europe, Asia, Latin America, and Israel. Baptist Health, on the other hand, is a full-service healthcare system that works to improve the health of the communities it serves. It is the first health system in the U.S. to have all its hospitals recognized by American Nursing Credentialing Center with either a Magnet® or Pathway to Excellence® designation for nursing excellence. 2. Need for Virtual Care The recent phase of the pandemic and the years of lockdown that followed it led to more remote services in all fields, including healthcare. What can be more wonderful than patients getting world-class treatment in any part of the globe with in-depth analysis from the comfort of their homes?! Primary care, emergency care, consultations, and regular check-ups could be provided. TytoCare's Home Smart Clinic solution goes beyond traditional audio and video telehealth services to offer a wider range of options, such as primary, urgent, preventive, chronic, and holistic care. It also provides user engagement services along with AI-powered diagnostic support. As a result, the company resolves almost 90% of visits without an in-person appointment! 3. Collaborating for a Better Future! Coming back to the collaboration part, Baptist Health would be incorporating two effective solutions of TytoCare, namely, TytoHome and TytoClinic. In the former service, patients would need to buy a monitoring device from Baptist Health, enabling a direct source of revenue. With the help of this device, the healthcare providers of Baptist Health would monitor and assist patients with chronic medical conditions. Also, TytoClinic would be an extension of Baptist Health, offering services in workplaces, schools, local clinics, etc. Nevertheless, TytoCare's Home Smart Clinic uses an FDA-approved handheld kit to examine the body's most essential organs. It also measures heart rate and body temperature, thus significantly treating many acute and chronic conditions. Besides, it allows healthcare clinicians to access vital clinical data to monitor, diagnose, and remotely treat patients.

Read More


SimiTree Announces Afia and GreenpointMed Acquisition

SimiTree | January 13, 2023

SimiTree has strengthened its position in the US behavioral health support market by acquiring two new companies. On January 12, 2023, Bill Simione, CEO and Managing Principal of SimiTree, announced the acquisition of behavioral health data analytics and consulting firm Afia and Florida-based credentialing service provider GreenpointMed. This move enhances the full range of support services offered by SimiTree and its behavioral health flagship, Infinity Behavioral Health Services. Afia employs data-driven decision-making to address business challenges by streamlining EHR implementations, optimizing revenue cycles, promoting clinical best practices, and developing IT infrastructures to advance behavioral businesses. SimiTree's leading data analytics capabilities are enhanced by this acquisition, allowing clients to benefit from tech-enabled optimization of financial, clinical, and operational functions and gain greater insight from actionable data. Acquiring GreenpointMed has allowed SimiTree to expand billing and debt recovery capabilities and offer time-saving credentialing services with insurance panels to behavioral health providers. GreenpointMed has substantial credentialing experience in every state, with all insurers, including Medicare and Medicaid. "This move delivers the scalability SimiTree needs to address the behavioral health industry's growing need for our services as we head into 2023," said Bill Simone. He further added, "We remain committed to providing a robust array of services to assist behavioral health providers in developing a stronger revenue cycle with improved cash flow, higher collection rates, and best-in-class processes." (Source – PR Newswire) About SimiTree Formed by the merger of Simione Healthcare Consultants with BlackTree Healthcare Consulting in 2021, SimiTree provides clinical, financial, operational consulting and outsourced services such as review choice demonstration (RCD), OASIS, billing, coding, and quality assessment and performance improvement (QAPI). Headquartered in King of Prussia (Pennsylvania), the company aligns its teams, services, and approach with clients' challenges to help them improve operational performance, fulfill clinical and financial potential, and improve the organization's overall health.

Read More


Tandem Diabetes Care Successfully Acquires AMF Medical SA

Tandem Diabetes Care | January 24, 2023

On January 23, 2023, Tandem Diabetes Care, Inc., a company specializing in diabetes technology, announced that it had successfully finished acquiring AMF Medical SA, a Switzerland-based medical equipment manufacturer that created the Sigi Patch Pump. Sigi Patch Pump is a rechargeable, ergonomic patch pump intended to lower the strain of managing diabetes by utilizing pre-filled insulin cartridges. It is currently under development and is not available for retail purchase. John Sheridan, President and Chief Executive Officer of Tandem Diabetes Care, said, "AMF Medical's compelling technology aligns well with our strategic vision to include a patch pump in Tandem's portfolio of differentiated offerings." He adds, "In addition to this innovative technology, the talented AMF team joining our Tandem family shares our commitment to simplify diabetes management and brings decades of experience from the diabetes device, life sciences, and watch-making industries." (Source – Business Wire) For this transaction, Tandem Diabetes Care received legal counsel from Baker & McKenzie LLP and Bass, Berry & Sims PLC. AMF Medical relied on SVB Securities LLC as its sole financial advisor, while Homburger AG served as its exclusive legal advisor. About Tandem Diabetes Care Headquartered in San Diego (California), Tandem Diabetes Care, Inc. is a medical device company aiming to better the lives of people with diabetes through endless innovation and a novel customer experience. The company employs a fresh and user-centric approach when it comes to developing, designing, and commercializing products for those who need to use insulin. As a result, Tandem Diabetes Care is creating a positive difference by assisting in creating better outcomes for people affected by diabetes and their healthcare providers.

Read More